Ashland
ASH

$96.19

1.77%

Market Cap: 4.82B

About: Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. Ashland includes only U.S. and Canada in its North America designation and includes Europe, the Middle East and Africa in its Europe designation.

Employees: 3,800

Materials Chemicals & Allied Products, Wholesale

0

Funds holding %

of 6,702 funds

0

Analysts bullish %

of 8 analysts

0

News positive %

of 3 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

89% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 37

50% more funds holding in top 10

Funds holding in top 10: 4 [Q4 2023] → 6 (+2) [Q1 2024]

16.5% more ownership

Funds ownership: 75.82% [Q4 2023] → 92.33% (+16.5%) [Q1 2024]

13% more capital invested

Capital invested by funds: $3.97B [Q4 2023] → $4.5B (+$535M) [Q1 2024]

10% more funds holding

Funds holding: 330 [Q4 2023] → 363 (+33) [Q1 2024]

7% less repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 113

28% less call options, than puts

Call options by funds: $6.72M | Put options by funds: $9.33M

See Fund Rankings

Research analyst outlook

8 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target

$88

9%

downside

Avg. target

$106

10%

upside

High target

$126

31%

upside

8 analyst ratings

4 positive

50%

2 neutral

25%

2 negative

25%

BMO Capital John McNulty	9%upside $105	Market Perform Maintained	7 May 2024
JP Morgan Jeffrey Zekauskas	6%downside $90	Underweight Maintained	2 May 2024
UBS Joshua Spector	21%upside $116	Buy Maintained	1 May 2024
Mizuho John Roberts	14%upside $110	Buy Maintained	1 May 2024
Wells Fargo Michael Sison	16%upside $112	Overweight Upgraded	11 Apr 2024

See Analyst Rankings

Financial journalist opinion

Based on 3 articles about ASH published over the past 30 days

Zacks Investment Research

ASH or NVZMY: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Chemical - Specialty sector have probably already heard of Ashland (ASH) and Novozymes A/S (NVZMY). But which of these two stocks presents investors with the better value opportunity right now?

ASH or NVZMY: Which Is the Better Value Stock Right Now?

Zacks Investment Research

ASH vs. NVZMY: Which Stock Is the Better Value Option?

Investors looking for stocks in the Chemical - Specialty sector might want to consider either Ashland (ASH) or Novozymes A/S (NVZMY). But which of these two stocks offers value investors a better bang for their buck right now?

ASH vs. NVZMY: Which Stock Is the Better Value Option?

Ashland sets date for fiscal 2024 third-quarter earnings release and conference call webcast

WILMINGTON, Del., July 17, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its third-quarter earnings release at approximately 5 p.m. ET on Tuesday, August 6, 2024. The company's live webcast with securities analysts will include an executive summary and detailed remarks. The live webcast will take place at 10 a.m. ET on Wednesday, August 7. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website at http://investor.ashland.com .

Ashland sets date for fiscal 2024 third-quarter earnings release and conference call webcast

Ashland achieves certification by Fair Wage Network

WILMINGTON, Del., June 18, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE:ASH) has strengthened its performance towards environmental, social and governance (ESG) practices and a more just and equitable society through a relationship with the Fair Wage Network (FWN) to understand living wages for the company's 3,800 global employees. Following a rigorous and thorough process where compensation data for all employees was reviewed on an anonymous basis and steps were taken to remediate any pay gaps, Ashland achieved certification as a Global Living Wage Employer .

Ashland achieves certification by Fair Wage Network

Zacks Investment Research

Ashland (ASH) Up 4% Since Last Earnings Report: Can It Continue?

Ashland (ASH) reported earnings 30 days ago. What's next for the stock?

Ashland (ASH) Up 4% Since Last Earnings Report: Can It Continue?

13 Upcoming Dividend Increases

Thirteen dividend increases are featured, with RLI Corp leading the charge with a 49-year streak and a potential to become a dividend king next year. The list is created by merging data from the "U.S. Dividend Champions" spreadsheet and upcoming dividend data from NASDAQ. The article provides additional metrics, tickers by yield and growth rates, and historical returns for investors to consider before making investment decisions.

13 Upcoming Dividend Increases

3 Future Breakout Stocks That Wall Street Is Already Loving

Investors looking for breakout stocks to buy that Wall Street already loves should find it easier now that the S&P 500 is near 52-week and all-time highs. The index is up nearly 12% year to date thanks to an almost 5% gain in the past month.

3 Future Breakout Stocks That Wall Street Is Already Loving

Zacks Investment Research

Ashland (ASH) to Divest Nutraceuticals Business to Turnspire

Ashland (ASH) is set to sell its nutraceuticals business to Turnspire Capital Partners, with the deal expected to close in third-quarter 2024.

Ashland (ASH) to Divest Nutraceuticals Business to Turnspire

Ashland Board appoints Ashish K. Kulkarni as new director

WILMINGTON, Del., May 08, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) is announcing the appointment of Ashish K. Kulkarni to its Board of Directors. Kulkarni is the CEO of Kebotix, a startup company focused on commercializing artificial intelligence methods into new material commercialization. He is the former executive vice president and chief innovation officer, GAF, former chief technology and innovation officer, Avantor and former chief technology and innovation officer, Celanese Corporation. He will serve on the Board's Environmental, Health, Safety and Quality, and Compensation Committees, effective May 6, 2024. Prior to Celanese, Kulkarni held leadership positions at United Technologies Corporation, American Standard and General Electric.

Ashland Board appoints Ashish K. Kulkarni as new director

Zacks Investment Research

Ashland (ASH) is a Top-Ranked Momentum Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Ashland (ASH) is a Top-Ranked Momentum Stock: Should You Buy?

See News Rankings